论文部分内容阅读
目的探讨尿激酶对提高包裹性脓胸介入治疗效果的应用价值。方法26例包裹性脓胸患者脓腔穿刺置管尿激酶灌注保留冲洗引流,2~3次/周,最长3周。结果26例治疗后体温均降至正常。CT或B超显示23例脓腔完全关闭,3例脓腔分隔明显减少,引流液减少,无明显并发症。结论尿激酶在包裹性脓胸介入治疗中的应用安全有效。
Objective To investigate the value of urokinase in improving the interventional treatment of encapsulated empyema. Methods Twenty - six patients with encapsulated empyema underwent purulent perforation and catheterization of urokinase for irrigation and drainage, 2 or 3 times a week for up to 3 weeks. Results After treatment, the body temperature dropped to normal in 26 cases. CT or B-ultrasound showed that 23 cases of abscess completely closed, 3 cases of abscess separation was significantly reduced drainage reduced, no significant complications. Conclusion The application of urokinase in encapsulated empyema intervention is safe and effective.